State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 256 actively recruiting studies with Arizona sites out of 256 registered in total. The busiest research areas in Arizona are Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia. Leading sponsors running trials in the state include Mayo Clinic, AstraZeneca, Eli Lilly and Company. By stage, Arizona trials break down as Phase 1 (46), Phase 2 (78), Phase 3 (70), Phase 4 (5).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 256 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 256. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT05701280 N/A
Recruiting
Pilot/Pivotal Study of DBS+Rehab After Stroke
Condition
Stroke
Enrollment
202 pts
Location
United States
Sponsor
Enspire DBS Therapy, Inc.
NCT07140783 Phase 3
Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Kerato...
Condition
Vision Loss Night
Enrollment
580 pts
Location
United States
Sponsor
Ocuphire Pharma, Inc.
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT05485675 N/A
Recruiting
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness...
Condition
Sedentary Behavior
Enrollment
4,800 pts
Location
United States
Sponsor
Arizona State University
NCT07113522 Phase 2
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Condition
Inflammatory Bowel Disease (IBD)
Enrollment
140 pts
Location
United States, Canada, Georgia
Sponsor
Mirador Therapeutics, Inc.
NCT05705531 N/A
Recruiting
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatm...
Condition
Cardiovascular Disorder
Enrollment
190 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT03683251 Phase 3
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Condition
Neovascular Age-Related Macular Degeneration
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07485205 N/A
Recruiting
Establishing Normative Urodynamics Parameters for the Glean Urodynamics System i...
Condition
Lower Urinary Tract Symptoms (LUTS)
Enrollment
72 pts
Location
United States
Sponsor
Bright Uro
NCT06568939 Phase 2
Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzuma...
Condition
Non-Small Cell Lung Cancer
Enrollment
150 pts
Location
United States, Brazil, China
Sponsor
AbbVie
NCT04726241 Phase 1, Phase 2
Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marr...
Condition
Acute Lymphoblastic Leukemia
Enrollment
960 pts
Location
United States, Australia, Canada
Sponsor
PedAL BCU, LLC
NCT07455383 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
NCT07384975 Phase 2
Recruiting
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa (HS)
Enrollment
150 pts
Location
United States, Bulgaria, Canada
Sponsor
Navigator Medicines, Inc.
NCT07553429 Phase 1, Phase 2
Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses o...
Condition
Diabetic Macular Edema
Enrollment
49 pts
Location
United States, Puerto Rico
Sponsor
Boehringer Ingelheim
NCT06556602 N/A
Recruiting
Methadone Patient Access to Collaborative Treatment
Condition
Opioid Use Disorder
Enrollment
1,080 pts
Location
United States
Sponsor
University of Arizona
NCT07616128 Phase 2
Recruiting
Study of EVO756 in Adults With Migraine
Condition
Migraine
Enrollment
330 pts
Location
United States
Sponsor
Evommune, Inc.
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT06846281 Phase 3
Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Particip...
Condition
Relapsing Multiple Sclerosis
Enrollment
400 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT07175038 Phase 2
Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pu...
Condition
Pulmonary Arterial Hypertension (PAH)
Enrollment
40 pts
Location
United States, Australia, Canada
Sponsor
AllRock Bio, Inc.
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
143 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT06819735 Phase 1, Phase 2
Recruiting
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint ...
Condition
Advanced Solid Tumors
Enrollment
125 pts
Location
United States, Australia, France
Sponsor
Domain Therapeutics Australia
NCT04071847 N/A
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Condition
Movement Disorders
Enrollment
1,000 pts
Location
United States, Australia, Finland
Sponsor
Abbott Medical Devices
NCT06980948 Phase 1, Phase 2
Recruiting
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Ne...
Condition
Chronic Neuropathic Pain
Enrollment
27 pts
Location
United States
Sponsor
Sangamo Therapeutics
NCT07258849 Phase 1
Recruiting
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Ar...
Condition
Rheumatoid Arthritis (RA)
Enrollment
141 pts
Location
United States, Germany
Sponsor
Eli Lilly and Company
NCT07205887 Phase 2
Recruiting
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular...
Condition
Neovascular Age-Related Macular Degeneration (NVAMD)
Enrollment
160 pts
Location
United States
Sponsor
EyeBiotech Ltd.
NCT06160206 Phase 2
Recruiting
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatmen...
Condition
Recurrent Glioblastoma
Enrollment
134 pts
Location
United States
Sponsor
Academic and Community Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology